Dong-A Pham plans to launch nine biological drugs by 2013 with hope of acquiring large shares in the global market.
To that end, the company will conduct clinical trials for six biological products to treat various diseases this year, including DA-3803 (hCG), DA-3031 (PEG-GCSF), DA-3021 (PEG-INF), DA-3003 (sr-hGH), DA-3501 (INF-) and DA-3601.
Last year, Dong-A made its $68 million export...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.